Abstract

Objective: To analyze the accuracy of frozen section (FS) examination of a borderline ovarian tumor (BOT) and the factors affecting it.Methods : We retrospectively evaluated 132 patients who were operated on in our clinic for ovarian mass between 1996 and 2016, who underwent FS examination and who had a BOT as a result of the final pathology. We investigated the Frozen accuracy, overdiagnosis and underdiagnosis rates and the factors affecting the accuracy of the diagnosis.Results : The mean age of the sample group was 44.6 ± 15.2 years. 50.8% of our patients were serous, 34.8% were mucinous and 14.4% were sero-mucinous in histology. Our Frozen Section accuracy rate was 75%, and underdiagnosis and overdiagnosis rates were 20.5% and 4.5%, respectively.The factors affecting the accuracy of the frozen section were histological type (p = 0.003), presence of solid component (p = 0.002) and preoperative CA 125 value (p = 0.001).Conclusion : Frozen examination has a low accuracy rate that affects the correct selection of surgical treatment for BOTs. FS should be performed by experienced gyneco-pathologists and it is necessary to consider carefully the factors that may cause misdiagnosis of the pathology.

Keywords: Borderline tumor, Ovary, Frozen section analysis, Overdiagnosis, Underdiagnosis

Downloads

Download data is not yet available.

Introduction

BOTs constitute approximately 15% of all ovarian neoplasia and show a behavioral pattern between benign cystadenoma and invasive carcinoma [1,2]. When compared with invasive carcinomas, BOTs are more commonly diagnosed at a young age and during fertility. One-third of cases are under 40 years of age [3,4]. Surgery is the standard treatment for BOTs, and the age of the patient, the stage of the disease, the desire for fertility, and the histopathological character of the tumor determine the extent of surgery. Priority should be given to conservative treatment for patients of a young age who wish to preserve fertility. BOTs are often initially diagnosed as tumors with benign characteristics in preoperative evaluations, so intraoperative FS examination becomes a critical point for the appropriate operative method.

In pathology, the frozen examination is referred to as ‘’Frozen Section “, or ‘’Intraoperative Consultation’’. As there is no normal follow-up procedure, technical artifacts are inevitable and determine the accuracy of the procedure. Further investigations (histochemistry, immunohistochemistry, molecular, etc.) applied in routine diagnosis cannot be performed or have limitations in the frozen section. Frozen section is crucial for the surgeon to determine the appropriate surgical method for the patient. Decisions on complete surgical staging and radicality of surgery (especially fertility-sparingg surgery) all depend on the results of FS. FS examination prevents unnecessary surgical procedures and reduces perioperative complications. However, Medeiros described the ‘’Frozen section’’ examination as a moderately useful diagnostic method in differentiating between benign and malignant tumors with a high accuracy rate but with relatively moderate efficiency in the discrimination of BOTs [5]. In this study, we wanted to investigate the diagnostic accuracy of FS in our clinic and the factors that may affect results.

Materials and Methods

A total of 132 patients with the diagnosis of an adnexal mass, who were operated on between October 1996 and April 2016, were included in the study. Ethics committee approval was obtained from Çanakkale 18 Mart University (date:11.03.2020/number:2020-05) prior to the study. The patients whose frozen examination was not performed, who had another primary malignancy and whose final pathology result was reported as “invasive ovarian tumor” were excluded from the study. Histological subtypes of BOTs were classified as serous, mucinous and sero-mucinous. The clinical characteristics of the tumors, in terms of the presence of solid compounds, were evaluated preoperatively by ultrasonography and/or computed tomography. The mass lesion was classified according to the uni/multi-cystic character and whether it included a solid area. The tumor diameter of the specimen, which was sent to the pathology laboratory without being fixed, was measured. The pathologist then made two to five cuts, depending on the size of the tumor. Frozen section examination was done based on the solid, papillary or necrotic areas of the mass lesion. Frozen section examination was done for both ovaries if the tumor was bilateral. İn all cases, a minimum of 1 section per 1 cm of maximal tumor diameter was examined for permanent section diagnosis. All the clinicopathological characteristics, FS and final pathology results of the persistent paraffin sections were examined for possible factors that may affect FS (age, histological type, tumor diameter, localization, tumor characteristics, presence of acid, preoperative CA 125 value). The presence of paraffin in the results was defined as the correct diagnosis (borderline). The results of the frozen section other than ‘’BOT’’ were considered as the wrong diagnosis. The term ‘underdiagnosis was used for benign frozen results and 'overdiagnosis' was used for a malignant frozen section result. Two pathologists experienced in gynecologic pathology evaluated two cases of frozen paraffin.

Statistical Analysis

The data were analyzed using SPSS version 20.0. For the presentation of the data, number, percentage, mean, standard deviation, median, minimum and maximum values ​​were used. The Chi-square test was used for the analysis of categorical data. P <0.05 was accepted for statistical significance.

Results

The mean age of our 132 patients was 44.6 ± 15.2 (median 44 .0) and 39.4% of the patients were 40 years or older. On histological examination, 67 (50.8%) serous BOTs were found, 46 (34.8%) mucinous and 19 (14.4%) sero-mucinous. Only 9 (6.9%) of our cases were bilateral and 7 of them had serous histology.

When the tumor diameter was examined, it was found to be 10.5 ± 5.7cm (median 9) in serous type, 21.0 ± 10.1cm (median 20) in mucinous type, and 10.7 ± 6.2 cm (median 8) in sero-mucinous type. Preoperative CA 125 levels were: 120.6 ± 198.6 U / ml (median 56.1 minimum (min) -maximal (max) 3-983) for serous BOTs; 49.9 ± 70.3 U / ml (median 23.8 min-max 2-375) for mucinous BOTs and 94.1 ± 104.9 U / ml (median 55.3 min-max 7.9-358) forsero-mucinous BOTs. No solid content was evident in 43.3% of our patients (42/97) who were evaluated by imaging methods in our records. The frequency of the mass lesion showed a homogenous distribution with regard to its uni/multi-cystic structure and including solid areas or not (Table 1).

n (%)
Purecystic/solidarea (-) 18 (19,6)
Multi cystic/solidarea (-) 22 (23,9)
Purecystic/solidarea (+) 31 (33,7)
Multi cystic/solidarea (+) 21 (22,8)
Table 1. Radiologic ( computed tomography / ultrasonography ) features of the study group

When FS results were examined, 20.5% (27/132) of tumor masses were diagnosed as ‘benign’ and 4.5% (6/132) were diagnosed as ‘malignant’. As a result, our correct FS diagnosis rate is 75%. When the factors which influenced diagnostic accuracy of FS was analyzed, while histological type of the tumor (p=0,003), presence of a solid component (p=0,002) and pre-operative CA125 value (p=0,001) were found to be significant, an association was not found between misdiagnosis and age, mass diameter, bilateral location and presence of acid (Table 2).

Underdiagnosis True diagnosis Overdiagnosis p
n=27 %20,5 n= 99 %75 n=6 %4,5
Age < 40 9 33,3% 41 41,4% 2 %33,3 0.709
≥40 18 66,7% 58 58,6% 4 %66,7
Histology Serous 7 25,9% 57 57,6% 3 50,0% 0.003
Muscinous 18 66,7% 27 27,3% 1 16,7%
Serous-muscinous 2 7,4% 15 15,2% 2 33,3%
Tumordiameter <5cm 4 15,4% 16 16,2% 1 20,0% 0.969
≥5cm 22 84,6% 83 83,8% 4 80,0%
Solid compound No 13 76,5% 26 34,2% 3 75,0% 0.002
Yes 4 23,5% 50 65,8% 1 25,0%
Bilaterality No 26 100,0% 90 90,9% 5 100,0% 0.078
Yes 0 0,0% 9 9,1% 0 0,0%
Ascite No 22 95,7% 81 90,0% 5 100,0% 0.417
Yes 1 4,3% 9 10,0% 0 0,0%
Preop.CA125serumlevel <35 IU/ml 18 81,8% 35 39,3% 1 20,0% 0.001
≥35 IU/ml 4 18,2% 54 60,7% 4 80,0%
Table 2. T he factors affecting the accuracy of the frozen section examination .

Discussion

FS examination first applied in 1816 is widely used for suspected ovarian masses [6]. The sensitivity and specificity of FS in differentiating benign and malignant neoplasms is 65-9% and 97-100%. On the other hand sensitivity and specificity for BOTS were found to be as follows: 25-92%, and 60-99% [7,8,9,10]. The FS accuracy for mucinous BOT is the lowest. Cross et al. described the case of the 267 mucinous borderlines, where the FS accuracy rate was given as 79% [11]. Brunve et al described another of the 107 mucinous BOTs, where the accuracy rate was 79% [12]. The low incidence of overdiagnosis in the literature and in our series is directly related to the experience of the pathologists, who play an important place in ensuring the correct diagnosis.Other factors such as imaging findings, clinical findings, tumor markers, and intraoperative findings and communication with pathologists may also contribute to increased intraoperative FS accuracy [13]. While Gültekin et al. emphasized that under-diagnosis was 3.3 fold greater in the subjects whose CA125 value was below 35 IU, CA125 level was below 35 IU in 18 out of 22 under-diagnosis cases. Another similarity with that study and ours is the fact that the frozen accuracy rate is high in the mass lesions which include a solid component and pure cystic mass morphology is more frequent in the underdiagnosis group [14]. In the Houck series, the rate of overdiagnosis was 10.7% and the rate of underdiagnosis was 29.3%. The non-serous histologic type was the determinant of false FS [15]. Tempfer et al. found that the rates of underdiagnosis and overdiagnosiswere 28% and 0% respectively. They stated that the only independent risk factor was tumor diameter and that the tumor diameter of < 20 cm was the sole factor of underdiagnosis [16]. Li et al. concluded that tumor size and histology are the causative factors of underdiagnosis [17]. Bilateral / unilateral existence of BOTs was not significant in our study and could not be demonstrated in the related literature [15,18]. A review of the literature, including rates of accuracy, overdiagnosis, and underdiagnosis of BOTs is given in Table 3.

Country Year Number Accuracy % Underdiagnosis % Overdiagnosis
Houck Usa 2000 140 60(84/140) 29,3(41/140) 10,7(15/140)
Kayıkcıoglu Turkey 2000 33 69,7(23/33) 30(7/23) 13(3/23)
Tempfer Austurıa 2007 96 71,9(69/96) 28(27/96) 0(0/96)
Kim K. S.Korea 2009 181 60,2(109/181) 6(11/181) 34(61/181)
Kim JH. S.Korea 2009 101 62,4(63/101) 32(32/101) 6(6/101)
Li China 2009 73 75,3(55/73) 25(18/73) 0(0/73)
Shih KK. Usa 2011 120 86,7(104/120) 0,8(1/120) 13(15/120)
Song T S.Korea 2011 354 64,4(228/354) 31(108/354) 5(18/354)
Basaran D. Turkey 2014 59 62,7(37/59) 31(18/59) 7(4/59)
Huang Z. Chına 2018 155 81,9(127/155) 14(22/155) 4(6/155)
Ourstudy Turkey 2019 132 75(99/132) 20,5(27/132) 4,5(6/132)
Table 3. Summary of studies in the literature

The FS accuracy rate obtained in our study was in accordance with data in the literature. Although literature data supported that frozen section number is a factor that influences the accuracy rate, unfortunately, we could not find data to confirm this in pathology records [19, 20]. As a result, BOT s in FS examination have low accuracy, low sensitivity, and low positive predictive value. Experienced gynecopathology experts are needed in order to reduce the rate of misdiagnosis rate. In any case, it is essential that surgeons and pathologists are fully aware of the potential risk factors for misdiagnosis.

References

  1. KarseladzeAI.WHOHistologicalClassificationOfOvarianTumors. ArkhivPatol. 2005 ;( Suppl):1.
  2. Skírnisdóttir I, Garmo H, Wilander E, Holmberg L. Borderline ovarian tumors in Sweden 1960–2005: trends in incidence and age at diagnosis compared to ovarian cancer. Int J Cancer. 2008; 123:1897– 1901.
  3. Harter P, Gershenson D, Lhomme C, et al. Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors). Int J Gynecol Cancer. 2014; 24:S5–S8.
  4. Akeson M, Zetterqvist BM, Dahllof K, Jakobsen AM, Brannstrom M, Horvath G. Population-based cohort follow-up study of all patients operated for borderline ovarian tumor in western Sweden during an 11-year period. Int J Gynecol Cancer. 2008; 18(3):453–459. Doi: 10.1111/j.1525-1438.2007.01051.
  5. Medeiros LR, Rosa DD, Edelweiss MI, et al. Accuracy of frozensection analysis in the diagnosis of ovarian tumors: a systematic quantitative review. Int J Gynecol Cancer. 2005;15:192–202
  6. Challis D. Frozen section and intra-operative diagnosis. Pathology 1997; 29:165-74.
  7. Geomini P, Bremer G, Kruitwagen R, Mol BW. Diagnostic accuracy of frozen section diagnosis of the adnexal mass: A metaanalysis. GynecolOncol 2005; 96:1-9.
  8. Abudukadeer A, Azam S, Zunong B, et al. Accuracy of intra-operative frozen section and its role in the diagnostic evaluation of ovarian tumors. Eur J GynaecolOncol. 2016; 37(2):216-220.
  9. Khan AH, Mamoon N, Usman M, et al. Accuracy of intra-operative frozen section in the diagnosis of female genital tract neoplasms. J Pak Med Assoc.2016; 66(2):143-146.
  10. Ayhan A, Ozler A, Dursun P, et al. Potential role of increasing number of sections in frozen section diagnosis of ovarian tumors. J ExpTherOncol. 2016; 11(4):245-250.
  11. Cross PA, Naik R, Patel A, Nayar AG, Hemming JD, Williamson SL, Henry JA, Edmondson RJ, Godfrey KA, Galaal K, Kucukmetin A, Lopes AD (2012) Intra-operative frozen section analysis for suspected early-stage ovarian cancer: 11 years of Gateshead Cancer Centre experience. BJOG 119(2):194–201
  12. Brun JL, Cortez A, Rouzier R, Callard P, Bazot M, Uzan S, et al. Factors influencing the use and accuracy of frozen section diagnosis of epithelial ovarian tumors. Am J ObstetGynecol 2008; 199:244-7.
  13. Bige O, Demir a, Saygili U, Gode F, Uslu T, Koyuncuoglu M. Frozen section diagnoses of 578 ovarian tumors made by pathologists with and without expertise on gynecologic pathology. GynecolOncol. 2011; 123:43–46.
  14. Gultekin E, Gultekin OE, Cingillioglu B, Sayhan S, Sanci M, Yildirim Y. The value of frozen section evaluation in the management of borderline ovarian tumors. J Can Res Ther 2011; 7: 416-20.
  15. Houck K, Nikrui N, Duska L, Chang Y, Fuller AF, Bell D, et al. Borderline tumors of the ovary: Correlation of frozen and permanent histopathologic diagnosis. ObstetGynecol 2000; 95:839-43.
  16. Tempfer CB, Polterauer S, Bentz EK, Reinthaller A, Hefler LA. Accuracy of intraoperative frozen section analysis in borderline tumors of the ovary: A retrospective analysis of 96 cases and review of the literature. GynecolOncol 2007; 107:248-52.
  17. Li M, Liu YH, Zhuang HG, Lin HH, Zeng RH, Wang XB, et al. Analysis of diagnosis accuracy of frozen sections in 73 cases of borderline tumor of ovary. Zhonghua Bing Li XueZaZhi 2009; 38:106-9.
  18. Song T, Choi CH, Kim HJ, et al. Accuracy of frozen section diagnosis of borderline ovarian tumors. GynecolOncol. 2011; 122(1):127-131.
  19. Pongsuvareeyakul T, Khunamornpong S, Settakorn J, et al. Accuracy of frozen-section diagnosis of ovarian mucinous tumors. Int J GynecolCance. 2012; 22(3):400-406.
  20. Tangjitgamol S, Jesadapatrakul S, Manusirivithaya S, et al. Accuracy of frozen section in diagnosis of ovarian mass Source. Int J Gynecol Cancer.2004; 14: 212-219.